BioXcel Therapeutics, Inc.
Accounts: BioXcel Therapeutics, Inc.
- Dividends paid 2025
- No dividend
From the stored figures
- Revenue went from $375k in 2022 to $642k in 2025 (+71%).
- Reported workforce went from 50 (2020) to 74 (2023).
Cuts against payouts
Jobs cut each year (tracker events) beside dividends and buybacks paid that year
Jobs: confirmed figures, else the stated "up to"; estimates and rumours not counted. Figures from SEC EDGAR XBRL, SEC annual filing. Original reporting currency. "Not available" means no stored figure; nothing is estimated.
Revenue and profit
Revenue as bars; pre-tax and net profit to shareholders as lines
Figures from SEC EDGAR XBRL, SEC annual filing. Original reporting currency. "Not available" means no stored figure; nothing is estimated.
Dividends and buybacks
Cash paid to shareholders each year; buybacks shown separately
Figures from SEC EDGAR XBRL, SEC annual filing. Original reporting currency. "Not available" means no stored figure; nothing is estimated.
Workforce
Year-end headcount the company reports; triangles mark job-cut events
Headcount from annual filings. Cuts from the tracker's events.
Revenue and profit per employee
Each year's stored figure divided by that year's reported headcount
Figures from SEC EDGAR XBRL, SEC annual filing. Original reporting currency. "Not available" means no stored figure; nothing is estimated.
Every figure and its source
Original currency. Tap a figure to open its filing.
2025
2024
2023
2022
2021
- Revenue
- Not available
- Pre-tax profit
- Not available
- Net profit to shareholders
- −$107m
- Cash dividends paid
- Not available
- Dividend per share
- Not available
- Share buybacks
- Not available
- Year-end workforce
- Not available
2020
2019
- Revenue
- Not available
- Pre-tax profit
- Not available
- Net profit to shareholders
- −$33m
- Cash dividends paid
- Not available
- Dividend per share
- Not available
- Share buybacks
- Not available
- Year-end workforce
- Not available
2018
- Revenue
- Not available
- Pre-tax profit
- Not available
- Net profit to shareholders
- −$19m
- Cash dividends paid
- Not available
- Dividend per share
- Not available
- Share buybacks
- Not available
- Year-end workforce
- Not available
2017
- Revenue
- Not available
- Pre-tax profit
- Not available
- Net profit to shareholders
- −$5m
- Cash dividends paid
- Not available
- Dividend per share
- Not available
- Share buybacks
- Not available
- Year-end workforce
- Not available
2016
- Revenue
- Not available
- Pre-tax profit
- Not available
- Net profit to shareholders
- Not available
- Cash dividends paid
- Not available
- Dividend per share
- Not available
- Share buybacks
- Not available
- Year-end workforce
- Not available
0 of 10 years complete · checked 28 Oct 2026 · SEC CIK 1720893
Gaps (10)
- 2016: revenue, pre-tax profit, net profit to shareholders — before the first machine-readable filing
- 2017: revenue, pre-tax profit — not tagged in the filing
- 2018: revenue, pre-tax profit — not tagged in the filing
- 2019: revenue, pre-tax profit — not tagged in the filing
- 2020: revenue, pre-tax profit — not tagged in the filing
- 2021: revenue, pre-tax profit — not tagged in the filing
- 2022: pre-tax profit — not tagged in the filing
- 2023: pre-tax profit — not tagged in the filing
- 2024: pre-tax profit — not tagged in the filing
- 2025: pre-tax profit — not tagged in the filing
Queued: company annual-report search for 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025, from 29 Oct 2026.